BioTrove

About:

Gene Analysis

Website: http://www.biotrove.com

Top Investors: Excel Venture Management, Technology Partners, Zero Stage Capital, Fletcher Spaght, Inc., CB Health Ventures

Description:

BioTrove, Inc. provides micro and nano-scale technology platforms for life science and drug discovery research applications. The company offers OpenArray, a technology platform for relative gene expression analysis that advances genomic research in various life science fields, including agriculture, disease research, and public health; RapidFire, a technology platform that enables the screening of intractable drug targets via mass spectrometry based assay development; and RapidFire mass spectrometry hardware system, a native detection technology for drug screening and in vitro ADME applications.

Total Funding Amount:

$41.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Woburn, Massachusetts, United States

Founded Date:

1997-01-01

Founders:

Colin Brenan, Tanya Kanigan

Number of Employees:

51-100

Last Funding Date:

2009-04-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai